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We undertook a randomized, double-blind, crossover study in 14 healthy women who were
required to ingest a 6-day low protein diet supplemented with CaSR-AAA (calcium-sensing
receptor-activating amino acids), DAA (dibasic amino acids) or methylcellulose capsules
(control). All subjects ingested all three diets in random order. Prior to each experimental diet
subjects consumed an 11 day adjustment diet. Calcium absorption was measured on day 5 of
each dietary intervention using dual-stable calcium isotopes. The clinical trial tested the
hypothesis that dietary protein affects the efficiency of intestinal calcium absorption by activating
the calcium sensing receptor (CaSR). Supplementation with CaSR-AAA did not significantly
increase Ca absorption. However, a trend towards improved Ca absorption was observed with
DAA (25.2±1.4% vs. 22.3±1.4%, P=0.094).
To further elucidate the mechanisms by which dietary protein improves Ca absorption, we
established and validated a 45Ca in vitro transport model. Differentiated Caco-2 cells were
exposed to different concentrations of amino acids for 6 and 72 hours. Prolonged amino acid
treatment significantly enhanced total transepithelial Ca transport (P=0.0048).
Subsequent in vitro studies utilized our recently validated transport model and focused on the
functional role of Cldn-2 in total transepithelial Ca transport. Cldn-2 is a tight junction protein that
was previously shown to be upregulated by dietary protein in rats. Total transepithelial Ca
transport was significantly reduced when Cldn-2 was stably knocked down in Caco-2 cells (P<
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0.0001). The contribution of Cldn-2 to amino acid-induced increases in Ca transport will be
explored in future studies.
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Chapter 1:
Introduction

There is an increasing interest in finding dietary alternatives for both prevention and treatment of
bone loss as osteoporosis continues to afflict an estimated 10 million people in the United
States. Environmental factors such as nutrition play an important role in causing and preventing
osteoporosis. In particular, dietary protein is an important nutrient that affects the way our
bodies handle Ca. The primary focus of this dissertation was to begin to elucidate the
mechanisms by which dietary protein improves Ca absorption efficiency by pursuing three
specific aims: 1. determining which functional group of amino acids is most responsible for the
effects of dietary protein on intestinal calcium absorption, 2. developing an in vitro transport
system to assess the direct effect of amino acid on enterocyte Ca transport, 3. evaluating the
functional role of tight-junction protein Claudin-2 (Cldn-2, a gene hypothesized to be involved in
dietary protein’s effects on Ca absorption) in total transepithelial Ca transport.
Chapter 2 reviews macronutrient regulation of intestinal Ca handling. The chapter summarizes
epidemiological, clinical, animal and in vitro research that explores the effects of carbohydrates,
fat and/or protein on Ca absorption and transport.
Chapter 3 is currently in the first review for publication in The Journal of Nutrition. This chapter
is dedicated to specific aim 1, that is to determine which functional group of amino acids is most
responsible for the effects of dietary protein on intestinal calcium absorption. This human
intervention trial sought to recapitulate the effect of increasing dietary protein on Ca absorption
by adding selected groups of amino acids to a low protein diet (0.7 g/kg/d) such that their total
dietary content is equal to that of our previously published high-normal protein diet (2.1 g/kg/d).
Supplementing a low protein diet with dibasic amino acids (arginine and lysine) resulted in a
trend towards increased Ca absorption.
1

Chapter 4 contains in vitro experiments designed to pursue specific aim 2 and 3. We developed
a 45Ca transport model in Caco-2 cells to assess the direct effect of amino acids on enterocyte
Ca transport. Our preliminary results demonstrate significant increases in total transepithelial Ca
transport with prolonged, but not acute, amino acid treatments. Alternatively, we utilized our in
vitro model to evaluate the role of Clnd-2 in total transepithelial Ca transport. Previously, Cldn-2
was identified as a tight-junction protein whose expression is increased in rats consuming a high
protein diet. This novel finding fostered further investigation of this gene in Ca transport. Stable
suppression of Cldn-2 resulted in a significant reduction in total transepithelial Ca transport.
Future studies will evaluate the functional role of Cldn-2 in amino-acid induced increases in Ca
absorption.
Chapter 5 summarizes finding from the in vivo and in vitro studies presented in Chapters 3 and
4. As a follow up to the completed experiments, potential studies addressing current research
gaps are proposed in this chapter.
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Chapter 2:
Macronutrient regulation of calcium transport: a mini-review

Introduction
Dietary Ca is absorbed by both transcellular and paracellular mechanisms. When Ca intake is
low, the ATP-dependent transcellular calcium transport pathway predominates in the upper
duodenum. The three step process involves: apical Ca entry via Transient Receptor Potential
cation channel, subfamily V, member 6 (TRPV 6) and to a lesser extent, by TRPV 5, facilitated
diffusion of Ca by calbindin-D9k and basolateral extrusion via plasma membrane Ca ATPase
(PMCA1b) or the Na+/Ca2+-exchanger (NCX1) (1). Down regulation of the transcellular Ca
transport pathway results from a normal or high dietary Ca intake, and in turn, paracellular Ca
absorption increases throughout the small intestine (2). Passive Ca absorption has previously
been defined as ion selective diffusion through the tight-junction of epithelial cells. However,
increasing interest in the area of heritable disease states has drawn attention to the protein
composition of the tight junction (1). The tight junction is comprised of transmembrane proteins,
cytoplasmic scaffolding proteins and cytoskeletal proteins that create a dynamic and regulated
environment. Particularly, transmembrane proteins, claudins (Clnds) and occludin, have a
functional role in selective ion permeability (1, 3, 4). For instance, Cldn-2 forms channels that
increase tight junction permeability of water and sodium (5, 6).
Vitamin D is the most well-established nutritional regulator of Ca absorption (2). 1,25dihydroxyvitamin D mediates active Ca transport by increasing expression of brush-border
membrane Ca channels, calbindin-D9k and the basolateral extrusion system (1). 1,25dihydroxyvitamin D increases the expression of two Ca-selective tight junction pore formers,
Cldn-2 and -12, which suggests a novel regulatory function of vitamin D in paracellular Ca
transport (7). Alternatively, macronutrient regulation of Ca absorption has been an area of
3

much debate for over half a century. This mini-review summarizes past and emerging research
demonstrating modulation of the Ca absorption pathway, with a primary emphasis on the
paracellular transport route, by dietary carbohydrates, fat and protein, and calls attention to
areas requiring further investigation.
Effect of select carbohydrates on calcium absorption
Since the 1940’s, milk has gained the attention of nutritionists for its rich Ca content and impact
on bone health (8). Therefore, it is not surprising that other constituents of milk have been
evaluated for their potential Ca absorption enhancing properties. The lactic acid byproduct from
the metabolism of “milk sugar” or lactose by lactobacilli was previously hypothesized to lower
pH content of the gastrointestinal tract, providing a mechanism by which lactose increases Ca
absorption (9). The acidic pH hypothesis was briefly replaced with the theory that certain mono-,
di- and oligosaccharides are osteogenic stimulators (10). However, research demonstrating the
rapid acting effects of lactose on Ca absorption challenged the bone cell theory, and the
potential Ca absorption/retention enhancing properties of lactose were revisited. Subsequent
studies in rats demonstrated an increase in femur 85Sr uptake (considered an index of Ca
absorption) following co-administration of Ca and lactose in a segment of the ileum compared to
Ca alone, or Ca and lactose in adjacent segments (11). An acute oral dose of lactose enhanced
Ca absorption above that seen with the control dose, and to a slightly greater extent than lysine
treatment (11), which has also been proposed to increase Ca absorption in rats and humans
(12, 13). Conversely, two week feeding of glucose or lactose had no effect on 45Ca femur
content (11). However, injecting carbohydrates including lactose into ileal sacs from rats
resulted in increased 45Ca femur content with all administered carbohydrates within 4 hours
after treatment. The slow rate of carbohydrate absorption was proposed as the mechanism by
which carbohydrates exert an effect on Ca absorption, thus enabling them to reach the lower
segment of the small intestine. The enhancing effect was not observed in the duodenum (9).
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Additional research in animal models corroborates these findings (14, 15). These results
suggest that carbohydrates including lactose, glucose, sucrose and fructose would more likely
exert an effect on the paracellular absorption route rather than the transcellular Ca transport
pathway, as the predominate enhancing effect was observed in the ileum and not the
duodenum (2). Furthermore, TRPV6, the primary apical transporter involved in transcelluar Ca
transport, is highly expressed in the duodenum, and present at a much lower extent in the
ileum, making it less likely that the aforementioned carbohydrates would impact TRPV6
expression (1).
Schuette and colleagues undertook a jejunal perfusion study in 16 healthy adults to assess the
effect of lactose and the combination of glucose and galactose on calcium absorption (16).
Lactose did not significantly alter Ca absorption compared to control or treatment with
glucose/galactose. Yet, glucose/galactose, the monosaccharides found in lactose, significantly
increased net Ca absorption compared to mannitol (control). Water and sodium permeability
paralleled Ca absorption. A solvent-drag effect was proposed as the mechanism by which
simple carbohydrates could enhance paracellular Ca absorption. More recently, a cross-over
trial in eleven lactose tolerant men and women examined the effect of lactose on fractional Ca
absorption using pharmokenetics of orally administered strontium (17). Subjects ingested a
bolus of lactose, glucose and galactose, or control (strontium alone) in random order. Food
record analysis revealed consistency in kcals, carbohydrate, fat, protein, calcium and
phosphorus intake between the three study groups 4-days prior to each Ca absorption
assessment. There were no significant differences in Ca absorption 240 min after ingestion of
either carbohydrate bolus or control, suggesting a one-time bolus of lactose is ineffective in
enhancing Ca absorption in this population. However, the study had limitations. Compared to
the oral strontium bolus employed by Zittermann et al. to evaluate fractional Ca absorption,
dual-stable Ca isotopes would have provided a more accurate assessment as they are
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considered the preferred methodology (18). Dietary intake prior to each absorption test was not
tightly controlled. The relatively small sample size and short duration may have precluded the
investigators from capturing a measurable effect. Lastly, the decline in lactase from childhood to
adulthood is well-established, with the majority of the world’s adult population being effected
(19). Thus, it is not unreasonable to question the appropriateness of the selected population.
Population based studies have demonstrated that for a variety of ethnic groups expression of
lactase is much higher in infancy than in adulthood (20), suggesting that lactose
supplementation in the early stages of life may provide beneficial effects. An acute study in
tube fed preterm infants examined the effect of lactose and glucose polymers on Ca absorption
(21). Ca absorption was higher in the presence of glucose polymers compared to lactose. The
study evaluated Ca absorption 1 hour post feeding and did not assess the impact of chronic
carbohydrate ingestion on intestinal Ca handling. In a second study of longer duration, Ca
absorption was evaluated by dual-stable Ca isotopes in 18 infants receiving both lactose and
lactose-free, maltodextrin based formulas in a randomized, cross-over fashion (22).
Consumption of lactose containing formula for two weeks resulted in significantly higher Ca
absorption. Zinc absorption was unaltered by the carbohydrate composition of the formula,
suggesting that the effect of lactose may be specific to Ca. Lactose as well as other
carbohydrate based formulas may enhance Ca absorption in infancy. However, the overall
effect of carbohydrates on Ca economy throughout the lifespan is, if at all, modest and requires
further investigation.
Effect of certain fatty acids and total fat intake on calcium absorption and transport
The effect of fatty acids, most notably conjugated linoleic acid (CLA), on calcium transport has
been investigated in Caco-2 cells. Jewell and Cashman assessed calcium transport in fully
differentiated Caco-2 Bbe cells after acute and chronic exposure to linoleic acid, capric acid,
lauric acid, a CLA blend or CLA isomers (23). Total transepithelial 45Ca transport and estimated
6

transcellular Ca transport were unaffected by both acute and chronic fatty acid treatments.
Compared to the control treatment (vehicle), chronic exposure to capric acid, lauric acid, and
trans-10, cis-12 CLA isomer significantly increased fluorescein flux, a non-specific marker of
paracellular permeability, and decreased TEER. Conversely, subsequent reports have
demonstrated significant increases in total transepithelial, transcellular and paracellular calcium
transport in 14-day old Caco-2 cells exposed to CLA isomers (24, 25). Specifically, Jewell et al
reported the addition of cis-9, trans-11 or trans-10, cis-12 CLA isomers to regular culture media
for 14 days significantly augmented the three assessments of Ca flux compared to vehicle or
linoleic acid treatment (24). Murphy et al demonstrated a significant increase in Ca transport
after 12 days of trans-10, cis-12 CLA isomer treatment compared to linoleic acid treatment (25).
Alternatively, transport was unaltered in cells exposed to the cis-9, trans-11 CLA for 12 days.
The inconsistencies in culturing periods between Jewell and Cashman’s report and the two later
studies may explain their discrepant findings. Although Jewell et al reported no differences in
alkaline phosphatase and aminopeptidase N activity in cells cultured for 14 days versus 22 days
(24), the activity of brush border membrane enzyme sucrase-isomaltase has been shown to
change throughout a 21 day culture period (26). Transport of 45Ca was 1.8-fold higher in vehicle
treated cells cultured for 14 days compared to cells cultured for 22 days (23, 24). Additionally,
paracellar transport of fluorescein was approximately 9.4-fold higher in cells exposed to trans10, cis-12 CLA for 12 days with a culture period of 14 days compared to a 22 day treatment and
culture period (23, 25), which provides evidence for differences in monolayer leakiness over
various culturing periods. Furthermore, passage number of Caco-2 cells, which was not
documented by Jewell and Cashman (23) or Murphy et al (25) can influence the expression of
nutritionally relevant transporters and activity of brush border enzymes (27), and may have
contributed to the observed difference.
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Murphy and colleagues also investigated fatty acid-induced alterations in global gene
expression in Caco-2 cells. Expression of calcium transport regulatory proteins, VDR and
calbindin D9k, and tight junction protein, Clnd-4, were found to be upregulated more than 2-fold
by trans-10, cis-12 CLA isomer relative to linoleic acid treatment, which is consistent with the
observed isomer-specific effects on calcium transport. No effect was seen with cis-9, trans-11
CLA treatment. The authors noted that this is the first study to employ whole genome-wide
microarray screen to investigate the effects of different CLA isomers on genes involved in
calcium transport in an in vitro model of the intestines. This study provides mechanistic insight
into isomer-specific CLA induced increases in calcium transport. The increases in gene
expression of VDR and calbindin D9k by trans-10, cis-12 CLA provides rationale for the
observed increase in transcellular calcium transport. However, it is currently unclear as to how
the significant induction in Claudin-4 expression directly relates to calcium transport in the
intestine. Claudins are a family of transmembrane proteins which have been shown to regulate
paracellular transport of ions and water through the tight junctions of epithelia (28). A number of
tissues including the intestine and the renal collecting duct have been shown to express
Claudin-4 (29, 30). Claudin-4 has been characterized as a seal-forming claudin (31), however,
in the presence of Claudin-8 has been shown to form a Cl¯ specific channel in the tight junctions
of renal collecting duct cells (32). It is important to note that Murphy et al also demonstrated a
significant increase in Claudin-2, a calcium permissive tight junction protein (7), in response to
trans-10, cis-12 CLA by microarray screen, but this finding was not confirmed by quantitative
RT-PCR (25). More research regarding the effect of CLA isomers on claudin proteins in relation
to paracellular calcium permeability is warranted.
The association between dietary fat intake and Ca absorption was recently examined in a
retrospective analysis of dual-stable isotopic studies in postmenopausal women (33). Dietary
fat intake was positively associated with true fractional Ca absorption. The strongest association
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for fat intake and Ca absorption was seen in overweight women compared to obese and lean
women. Stepwise multiple regression analysis revealed that dietary fat intake was the second
most significant predictor of Ca absorption in all women. Neither carbohydrate nor protein intake
were independent predictors of Ca absorption in this model. However, predictors of Ca
absorption differed for premenopausal women, as fat intake was not considered an independent
predictor of Ca absorption for this age group. The data suggests that dietary fat intake may have
Ca absorption enhancing properties in older, but not younger women. Similarly, a stepwise
analysis of three dual-stable Ca isotope studies in 50 post-menopausal women found fat intake
to be a significant predictor of fractional Ca absorption (34). However, intervention trials
assessing the impact of dietary fat on Ca absorption at different stages of life are required to
better understand the interplay between dietary fat, age and Ca absorption in women.
Effect of dietary protein and select constituents on calcium absorption
Controversy continues to surround the effect of dietary protein on intestinal Ca absorption. Hunt
et al (35) and Ceglia et al (36), reported no differences in calcium absorption between different
levels of dietary protein when calcium intakes met or surpassed the RDA (35, 36) and dietary
phosphorous was not fixed (36). Higher calcium and phosphorus intakes could have masked
any potential regulatory actions of dietary protein on calcium absorption. Conversely, studies
using dual stable Ca isotopes report that in the short term, dietary protein profoundly affects
intestinal Ca absorption. In particular, Kerstetter et al demonstrated that as compared to a high
protein diet (2.1 g protein/kg/d), restricting dietary protein to 0.7 g protein/kg/d results in
hypocalciuria caused by a reduction in fractional intestinal Ca absorption (37). Additionally,
increasing dietary protein from 1.0 to 2.1 g protein/kg/d resulted in an increase in urinary
calcium that is not accompanied by evidence for increased bone resorption. The incremental
change in urinary calcium can be nearly quantitatively explained by the improvement in
intestinal calcium absorption that accompanies the increase in dietary protein (38). In this
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experiment natural food stuffs were used and the dietary content of calcium, sodium and
phosphorus were controlled so that they were the same or very similar on both the 1.0 g/kg and
2.1 g/kg protein diets. Dietary protein was increased using both animal and vegetable protein
sources.
The constituents of dietary protein responsible for the previously observed increases in Ca
absorption are unknown. In particular, caseinphosphopeptides (CPPS) which are a component
of milk as well as a digestion product of casein have been hypothesized to increase Ca
absorption. Ca binding to CPPS maintains Ca solubility and increases the bioavailability of Ca
in the small intestine (39). However, data in animal models have provided inconsistent results.
The effect of CPPS on Ca absorption was previously assessed in normal and rachitic chicks
using inverted gut sacs and ligated duodenal loop methodology (40). Ca absorption was
increased by CPPs in the duodenum and ileum in both chick models. Phosphate, which may be
released during the absorption of CPPS, had not effect on Ca absorption. These data suggest
that the effect of CCPS on Ca absorption may be independent of vitamin D and phosphate. In
overiectomized rats the effect of CPPS on Ca absorption was dependent on Ca intake (41).
Alternatively, an acute study in rats evaluated changes in Ca absorption when whey was
replaced with casein and mixed protein sources including CPPS. Type of protein source had
not effect on Ca absorption (42). A randomized, double-blind crossover study in
postmenopausal women examined the effect of a one-time dose of CPPS-supplemented milk
on urinary Ca (UCa) (43). CPPS-supplemented milk did not enhance UCa compared to control
milk. The study possessed some major limitations. There was no adjustment period prior to the
first dietary intervention and UCa collection. Besides Ca, other nutrients known to affect Ca
absorption were not controlled for between study visits and Ca absorption was not directly
measured. A more recent crossover, intervention trial assessed the effect of a one-time CPPS
bolus on intestinal Ca handling using dual stable Ca isotopes and reported no increase in Ca
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absorption with CPPS compared to control (44). Thus, the acute intervention period may not
have been of sufficient duration to see an effect.
There are obviously other components of dietary protein that could be responsible for the
previously observed increases in Ca absorption (37, 38). In particular, amino acids have been
hypothesized to have a direct effect on enterocyte Ca transport. Chapters 3 and 4 summarize
the current evidence supporting the role of amino acids in Ca absorption and paraceullular Ca
transport. In chapter 3 we evaluate the effect of select groups of amino acids on Ca absorption
in vivo. Subsequently, the potential mechanism by which amino acids exert an effect on the
enterocyte is explored in Chapter 4.
Conclusion
Macronutrient regulation of Ca absorption continues to be an area of much debate. Past and
current evidence concerning these nutrients is suggestive of macronutrient-induced alterations
in paracellular Ca transport, rather than transcellular pathway activation. It may be that
macronutrient regulation occurs at different critical stages throughout the lifespan, such as
infancy, childbearing years and post-menopause, with each macronutrient exerting an effect at
different periods. It would be of interest to examine the impact of macronutrients on intestinal Ca
handling in different age groups and sexes in longer-term clinical trials, as the response is likely
to vary between the different groups.
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Chapter 3:
Supplementing a low protein diet with dibasic amino acids results in higher
urinary calcium excretion in young women

Introduction
For nearly 90 years, we have known that dietary protein affects calcium metabolism (45). In a
meta-analysis of 26 clinical intervention trials in adults where dietary protein was manipulated
and urinary calcium was measured, there was a strong linear correlation of the two (46) such
that on average, for every 40 g increment in dietary protein, urinary calcium increases by 50 mg.
It was widely assumed that the skeleton was the principal source of the additional calcium.
Higher protein diets, particularly those including animal sources, generate a fixed metabolic acid
load due to the metabolism of sulfur-containing amino acids. The diet-induced acid load is
believed to be incompletely accommodated by renal mechanisms, therefore, requiring release
of buffer from bone. The liberation of alkali from bone requires osteoclast-mediated bone
resorption, which could over a prolonged period of time reduce skeletal mass (47-50). In support
of this hypothesis, balance studies in the 1970’s reported no change in intestinal calcium
absorption as dietary protein increased (51-57). However, more recent studies using dual stable
calcium isotopes found that in the short term, dietary protein significantly affects intestinal
calcium absorption (37, 38). In particular, Kerstetter et al demonstrated that increasing dietary
protein from 1.0 to 2.1 g/kg results in an increase in urinary calcium that is not accompanied by
evidence for increased bone resorption. The increment in urinary calcium observed by these
investigators was nearly quantitatively explained by a parallel improvement in intestinal calcium
absorption (38). Recent work using an experimental rat model found a similar effect of dietary
protein on intestinal calcium absorption (58). Initial rates of calcium uptake were increased in
brush border membrane vesicles (BBMVs) isolated from rats acclimated to a high protein diet
(40%) compared to BBMVs from rats consuming a low protein diet (5%), suggesting that protein
12

augments intestinal Ca absorption at least in part by increasing transcellular Ca uptake. The
constituents of protein-containing foods that are responsible for its effect on intestinal calcium
absorption remain unclear. One obvious candidate is amino acids.
Amino acids could impact calcium absorption by altering cellular metabolism in enterocytes or
act as extracellular agonists via cell surface receptors or acceptors. Regarding the latter
possibility, amino acids are known to be allosteric activators of the calcium-sensing receptor
(CaSR), which is expressed throughout the gastrointestinal tract (59). Phenylalanine, tryptophan
and histidine are the most potent activators of the CaSR (60, 61). Conigrave et al. (60) first
reported amino acid-induced activation of the CaSR at physiologic extracellular calcium
concentrations in HEK cells engineered to overexpress the receptor. Busque et al. (62) reported
that L- phenylalanine and L-tryptophan at concentrations comparable to those seen postprandially can stereoselectively allosterically activate the CaSR on gastric parietal cells both in
vivo and ex vivo. Work by Dawson-Hughes et al. (63) provides further evidence in support of the
hypothesis that the CaSR could mediate dietary protein-induced increases in intestinal calcium
absorption. They demonstrated that supplementing a low protein diet with phenylalanine and
histidine increased urinary calcium; although they did not directly measure intestinal calcium
absorption. Another group of amino acids that appears to have effects on intestinal calcium
absorption are the dibasic amino acids. In particular, dietary lysine supplementation was
reported to increase calcium absorption in individuals with osteoporosis (13). The mechanism
by which lysine supplementation induces changes in calcium absorption efficiency is unclear
and is likely independent of CaSR activation because lysine is minimally effective as a CaSR
agonist (60).
Despite these data, whether specific amino acids or dietary protein as a whole is responsible for
the protein-induced increases in calcium absorption remains unresolved. The current human
intervention trial was designed to determine if supplementing a low protein diet (0.7 g/kg) with
13

the CaSR activating amino acids (CaSR-AAA), tryptophan, phenylalanine and histidine, or the
dibasic amino acids (DAA), arginine and lysine, augments intestinal calcium absorption to an
extent comparable to that seen when dietary protein is increased from low to high.
Methods
Subjects
Sixty-five women (20-40 years old) with a body mass index (BMI, kg/m2) ranging from 18 to 28
were screened for eligibility. Subjects were recruited through flyers and advertisements in the
Yale Bulletin between the years 2010 and 2012. Recruitment was limited to non-Hispanic
Caucasian or Asian adults because these two ethnic groups are at highest risk for osteoporosis
(64). Potential subjects were excluded if they were taking medications known to affect calcium
metabolism (anti-osteoporotic medications, glucocorticoids, non-steroidal anti-inflammatory
medications, and birth control pills); were pregnant; reported excessive body weight change
during the past 6 months; followed intensive physical exercise regimens; smoked; had an eating
disorder, food allergies or followed medically prescribed diets; or had renal, gastrointestinal, or
bone disease; or amenorrhea. Subjects were asked to stop taking all multivitamin or mineral
supplements during the entire study. Throughout the study, subjects continued their usual
activities at home, school, or work except on days 5 and 6 of the three experimental periods, at
which time they were admitted to the Hospital Research Unit (HRU) of the Yale Center for
Clinical Investigation for measurement of calcium absorption. The study was approved by
human investigation committees at Yale University and the University of Connecticut. Informed
consent was obtained from each participant.
Experimental Design
Diets: The study protocol included 3 cycles, each consisting of an 11 day adjustment diet
followed by 6 days of an experimental diet. The three experimental low-protein diets (control,
14

CaSR-AAA supplementation, DAA supplementation) were provided in random order. The
experimental and adjustment diets are similar to those described in previous reports (37, 38,
65). The Yale Center for Clinical Investigation Research Dietitian and her staff prepared all
meals for every study subject during the feeding portion of the study (last 3 days of the
adjustment diet and 6 days of the experimental diet). For the first 8 days of each adjustment
period, subjects were instructed by the research dietitian to self-select their diets to contain a
dietary protein intake of 1.2 g/kg, 2300 mg (100 mmol) of sodium and 800 mg (20 mmol) of
calcium. The low-protein experimental diet (0.7 g/kg) consisted of variety of foods common to
the western diet and contained 800 mg (20 mmol) calcium, 2300 mg (100 mmol) sodium, 8001,200 mg (26–39 mmol) phosphorus and 13 grams of fiber. For each study subject, food items
remained the same on all three experimental diets. Each subject began with an energy intake of
30-36 kcal/kg (125–150 kJ/kg) and which was adjusted in 200-300 kcals/kg (840–1260 kJ/kg)
increments (with simple sugars and fats) during the experimental period to maintain body weight
within 1% of initial weight. The macronutrient and mineral composition of the experimental diets
was calculated from the U.S. Department of Agriculture Handbook No. 8 and manufacturer’s
information. The primary sources of calcium in the experimental diets were dairy foods and a
chewable calcium carbonate (Tums, GlaxoSmithKline, Pittsburgh, PA). Caffeine-containing
beverages were limited to one a day and alcohol was not permitted. Distilled water was
provided ad libitum. After the final urine collection on day 6, subjects resumed their usual,
unstructured diet, and subsequently participated in the second and third dietary cycles.
Amino Acid Supplements: L-amino acids were purchased from Ajinomoto Pharmaceuticals
(Ajinomoto Food Ingredients LLC, Chicago IL, 60631) and dispensed in capsules by the Yale
Investigational Drug Pharmacy. The total milligrams of supplemental amino acids for a given
day were divided among the three meals in amounts proportional to the total protein in each
meal. The amount of each amino acid added to the low-protein diet was the amount contained
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in the 1.4 g/kg increment in dietary protein required to increase protein intake from low (0.7
g/kg) to high (2.1 g/kg) (i.e. 2.1 - 0.7 = 1.4). Depending on a subject’s body weight, this required
between 5 and 7 capsules with each meal.
The average amino acid content (mg) per gram of total protein in the low and high protein diets
(shown in Table 1) was used as the basis for determining amino acid supplementation (37, 38).
A 60 kg female is used in the following example illustrating how amino acid supplementation
was calculated for the study. The baseline low protein diet for a 60 kg female subject would
contain 42 grams of protein (0.7 g/kg x 60 kg) consumed over 3 meals. The subject would
require 126 grams of protein (2.1 g/kg x 60 kg) on the high protein study diet. The increment in
dietary protein required to increase her protein intake from 0.7 g/kg to 2.1 g/kg is 84 grams. This
subject’s three experimental diets will be:
1. 42 g of protein plus placebo (methylcellulose).
2. 42 g of protein plus 2268 mg of histidine (27* X 84), 6384 mg of phenylalanine (76* X
84) and 924 mg of tryptophan (11* X 84).
3. 42 g of protein plus 4368 mg of arginine (52* X 84) and 5628 mg of lysine (67* X 84).
* These values were obtained by averaging the amino acid content of the low and high protein
diets previously utilized by Kerstetter et al (37, 38) and represent the mg of each amino acid per
gram of dietary protein (last column of Table 1).
Biochemical Sample Collection: Between Days 0 and 1 and Days 4 and 5, subjects collected
24-hr timed urine excretions for measurement of calcium, phosphorous, and sodium. On Day 1
and 5 of the experimental diet fasting blood was drawn for measurements of serum 1,25dihydroxyvitamin D, parathyroid hormone (PTH) and creatinine. Glomerular filtration rate (GFR)
was estimated from serum creatinine, age, sex, and race using the National Kidney Foundation
on-line calculator MDRD study equation. Serum levels of 25-hydroxyvitamin D were determined
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and corrected (if needed) in each study subject prior to beginning each adjustment diet to
assure a vitamin D-sufficient status. If the serum 25-hydroxyvitamin D was less than 67 nmol/L
but greater than 50 nmol/L subjects received a one-time correction dose of 50,000 IU of vitamin
D2. Subjects with a serum 25-hydroxyvitamin D level less than 50 nmol/L were given two
correction doses of 50,000 IU of vitamin D2 separated by five days. Serum 25-hydroxyvitamin D
was retested at least two weeks after supplementation. Subjects were not permitted to start their
adjustment diet until their serum 25-hydroxyvitamin D was at least 67 nmol/L.
Measurement of Intestinal Calcium Absorption: Intestinal calcium absorption was measured
using dual stable calcium isotopes as previously described (38). In brief, 0.125 mg of 44Ca/kg
body weight was administered orally in 3 divided doses with each meal in proportion to the
calcium content of the meal. The isotope was equilibrated in milk for 18-24 hours prior to
administration. Immediately after the breakfast meal on day 5, 0.02 mg of 42Ca/kg (for
experimental diets 1 and 3) or 0.004 mg/kg of 43Ca (for experimental diet 2) were administered
intravenously, after which urine was collected for the next 34 hours in three urine pools (8h, 12h,
14h). The intravenous isotope was changed for every other experimental diet to ensure that
there was no carryover of isotope from one diet to the next.
Calcium isotope ratios were measured using a Thermo Scientific Triton TI magnetic sector
thermal ionization mass spectrometer (TIMS; Thermo Fisher Scientific Inc, Bremen, Germany).
A ratio was made between each administered calcium tracer (42Ca, 43Ca and 44Ca) and another
naturally occurring calcium isotope (i.e.: 48Ca). Fractional calcium absorption was determined as
the ratio of the cumulative oral tracer recovery to the cumulative IV tracer recovery in the 34-h
urine collection obtained post-dosing. True calcium absorption was calculated as the product of
fractional calcium absorption and the calculated calcium intake (38).
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Assays: Twenty four hour urinary calcium, urinary phosphorous and serum creatinine were
measured on an AlfaWasserman ACE® analyzer (Alfa Wassermann Diagnostic Technologies,
LLC, West Caldwell, NJ). Urinary sodium was measured in the Clinical Chemistry Laboratory of
the Yale–New Haven Hospital. Intact PTH was measured by radioimmunoassay (Total Intact
PTH Assay, Scantibodies Laboratory Inc, Santee, CA). Vitamin D metabolites were measured
by radioimmunoassays (Diasorin, Inc Stillwater, MN).
Statistical Analyses: The estimated number of subjects required to detect a change in calcium
absorption is based on the hypothesis that adding CaSR-AAA to a low-protein diet will increase
intestinal calcium absorption to an extent similar to that observed when the subject’s dietary
protein intake is increased from 0.7 to 2.1 g/kg. Since it is possible that amino acids besides
those that activate the CaSR also affect intestinal calcium absorption, we estimated the effect
size for the CaSR-AAA to be approximately 70% of that seen with the 2.1 g/kg diet. We
reported that increasing dietary protein from 0.7 to 2.1 g/kg increased calcium absorption from
19 ± 5.0% to 26 ± 8.0% (an increment of 7±6.5%; P<0.01) (37). As just noted, to be
conservative we estimated an effect size approximately 30% less than that (a 5±6.5% increase
in calcium absorption). Using this effect size and standard deviation, a sample size of 14
provides a power of 0.80 with P=0.05 (calculated using GraphPad StatMate® version 2.0a for
Macintosh; GraphPad Software, San Diego, CA).
Analyses were performed using SPSS version 12.0 for Windows (SPSS Inc, Chicago, IL). The
graphical summary was generated using Prism software (version 4.0, 2004, GraphPad
Software). All values are presented as means ± SEM. The Shapiro–Wilks test was used to test
data for normality. All data were normally distributed except for serum 25-hydroxyvitamin D and
24-h urinary calcium at baseline and intact PTH at baseline and day 5 of all three interventions.
A repeated measures ANOVA or Friedman test (for non-normally distributed data) was used to
assess differences in baseline measures between the three experimental diets. A paired t-test
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or Wilcoxon signed ranked test (for non-normally distributed data) was used to assess
differences between each amino acid supplementation group and the control diet at day 5 and
differences between baseline (day 1) and day 5 of each experimental diet. A comprehensive
assessment of the primary outcome variable, intestinal calcium absorption, was performed by
calculating mean effect sizes for the two interventions. This was done by the following
calculation: mean absorption on the amino acid supplemented diet for the entire study group
minus the mean absorption on the control diet for all study subjects divided by the standard
deviation of the difference between the control diet and each amino acid supplemented diet
(66). A probability level of P ≤ 0.05 indicated statistical significance and P > 0.05 but < 0.10
indicated a trend.
Results
Figure 1 summarizes study subject recruitment, enrollment and randomization. Of the 65
subjects screened for eligibility, 51 subjects did not meet the inclusion criteria or were not
interested in participating after receiving a detailed explanation of the study. Fourteen healthy
premenopausal women with a mean age of 27.8 ± 1.2 and a BMI of 23.7 ± 0.9 were enrolled
and randomized.
Serum and Urine Metabolites
Serum 25-hydroxyvitamin D was within normal limits at the start of each subject’s adjustment
diet and was not significantly different between the three dietary interventions (control: 88.1 ±
4.8 nmol/L, CaSR-AAA: 88.1 ± 4.6 nmol/L, DAA: 87.5 ± 4.3 nmol/L, P=0.67) (67). Baseline
measures of serum and 24-h urine metabolites did not differ significantly between the three
diets (Table 2). Changes observed in calcium-related metabolites during the three experimental
diets are presented in Table 2. No significant differences were observed in 1,25dihydroxyvitamin D or intact PTH between baseline and day 5 of each intervention. Analyses of
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the day 5 values for PTH and 1,25-dihydroxyvitamin D revealed no significant differences
among the three interventions. Urinary sodium and GFR remained stable with no significant
differences observed at any time point for the duration of the study. As expected, GFR was
above 60 mL/min/1.73 m2 in all subjects throughout the entire study period. At day 5 urinary
calcium was lower than the value at baseline in all three experimental diets, however, this
change only reached statistical significance during the control diet (control: 37.4% mean
decrease, Z=-2.67, P=0.008; CaSR-AAA: Z=-0.91, P=0.36; DAA: Z=-1.48, P=0.14). At day 5,
urinary calcium was significantly greater with the DAA supplementation than the control diet
(P=0.039) (Table 2, Figure 2A). Twenty four-hour urinary phosphorus on day 5 of the three
study diets was found to be significantly lower than at baseline (control: P=0.001, CaSR-AAA:
P=0.047, DAA: P= 0.008).
Calcium Absorption
As shown in Table 2, there was no significant difference in calcium absorption between the diet
supplemented with CaSR-AAA and the control diet at day 5 (effect size = 0.12 ± 0.09, P=0.64).
However, there was a non-significant trend toward increased calcium absorption with DAA
supplementation as compared to the control diet (P=0.094), with 10 of the 14 subjects
evidencing higher absorption. Because dietary calcium was fixed at 20 mmol/d, intestinal
calcium absorption on the low protein diet supplemented with DAA was 0.6 ± 0.3 mmol/d higher
than on the control diet. Calculation of effect size revealed that this observed difference in mean
intestinal calcium absorption is considered to be a medium effect (0.54 ± 0.1) (68). As can been
seen in Figure 2, the increase in intestinal calcium absorption mirrored the change in urinary
calcium observed during the two diets. The mean difference in urinary calcium at day 5 between
the control and DAA supplemented diets was 0.9 ± 0.4 mmol/d.
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Discussion
We employed dual stable calcium isotopes to evaluate the effect of a low-protein diet
supplemented with either DAA or CaSR-AAA on intestinal calcium absorption. The intestinal
handling of calcium was not influenced by the addition of CaSR-AAA to a low protein diet. Shortterm supplementation with DAA resulted in a significant increase in urinary calcium and
augmented calcium absorption without significant changes in PTH or 1,25-dihydroxyvitamin D
during the three diet interventions, suggesting that the change in calcium excretion is due to
improved intestinal calcium absorption and not an induced renal calcium leak.
It is traditionally assumed that the dietary protein-induced increases in urinary calcium results
from the release of skeletal buffer and calcium in response to the metabolic load imposed by
sulfur-containing amino acids (47-50). Our data provide evidence for amino acid-induced
increases in urinary calcium independent of changes in dietary sulfur content, since arginine
and lysine do not contain sulfur. Therefore, the observed increase in urinary calcium is very
likely attributable to the rise in intestinal calcium absorption, rather than an increase in skeletal
catabolism.
Our laboratory has previously reported increased intestinal calcium absorption during a highnormal protein diet (2.1 g/kg), consisting of both animal and vegetable protein, when compared
to both low (0.7g/kg) and medium (1.0 g/kg) protein intakes (37, 38). In these prior studies dual
stable calcium isotopes were also used to assess calcium absorption, calcium was fixed at 19.820 mmol/d and nutrients known to affect calcium metabolism were tightly controlled. Under
these study conditions, when dietary protein was increased from 0.7 to 2.1 g/kg, intestinal
calcium absorption rose by 36.8% (37). The current study supplemented the same low protein
diet with the amount of the amino acids contained in the 1.4 g/kg increment in dietary protein
that was required to increase protein intake from 0.7 to 2.1 g/kg. Intestinal calcium absorption
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was 13% higher with dibasic amino acid supplementation compared to the low-protein control
diet. The change in calcium absorption in the present study reflects roughly a third of the
change in absorption observed when dietary protein was increased by 1.4 g/kg using mixed
food sources. Thus, the addition of DAA to the low protein diet did not increase intestinal
calcium absorption to the same extent as when dietary protein sources were manipulated.
However, DAA supplementation resulted in a quantifiable change in intestinal calcium
absorption which can explain 67% of the 0.9 mmol change in urinary calcium. Since intestinal
calcium absorption declines with aging and after menopause even a modest improvement in
intestinal calcium absorption could have long-term physiological significance. Thus, most
estrogen-deficient postmenopausal women are in negative calcium balance and an intervention
that improves calcium homeostasis could potentially protect against long-term deleterious
effects on skeletal integrity.
Research in animal models supports an effect of DAA on calcium economy (12, 69). Over 50
years ago, Wasserman et al. (69) measured 45Ca in the femur of young male rats after the
enteral administration of an individual amino acid bolus. Of the ten essential and eight nonessential amino acids studied, L-lysine followed by L-arginine resulted in the greatest
accumulation of 45Ca in bone. Compared to the control animals, administration of L-lysine and
L-arginine caused 1.7-fold and 1.6-fold increases in 45Ca accretion in bone, respectively. In
subsequent work, these investigators evaluated the interaction between lysine and other
nutrients known to effect calcium metabolism in vitamin D deficient rats (12). Treatment with Llysine or vitamin D enhanced calcium absorption above that seen with control treatment, but not
to the same extent as when they were provided in combination. The authors hypothesized that
L-lysine and vitamin D may be acting via different cellular pathways to increase intestinal
calcium absorption. Taken together, the studies by Wasserman et al and the present study
support the notion that additional studies to clarify the role of DAA in calcium metabolism are
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warranted. At present, it is unclear if DAA exert an effect on the transcellular, paracellular or
both calcium transport mechanisms.
The current study also evaluated a second group of amino acids (phenylalanine, tryptophan and
histidine) because they allosterically activate the CaSR. We found no effect of CaSR-AAA on
calcium absorption. In contrast, we found an increase in urinary calcium from the DAA
supplementation in comparison to the control. It is unlikely that the slight effect we observed of
DAA on intestinal calcium absorption is mediated by the CaSR. Conigrave et al. (60)
demonstrated that arginine and lysine were not very effective in activating the CaSR in HEK-293
cells stably expressing the receptor.
Dawson-Hughes et al. (63) examined the effects of selectively supplementing a low protein diet
with either CaSR-AAA, phenylalanine and histidine, or the branched chain amino acids (BCAA),
isoleucine and leucine, on urinary calcium. There was no significant difference in urinary
calcium between baseline and day 11 of amino acids supplementation for either study group or
between the two study groups at the end of the supplementation period. These findings are
consistent with the results of the present study where we found no significant change in urinary
calcium with CaSR-AAA supplementation. In a subsequent analysis, mean change in 24-hr
urine calcium was also compared between to the two groups (63). The addition of CaSR-AAA to
a baseline low protein intake of 0.5 g/kg resulted in an 11±9 mg increase in calcium excretion,
which was significantly different from the 20±9 mg decline in urinary calcium observed with
BCAA supplementation. In contrast to our study, urinary calcium did not change from baseline
during the two amino acid interventions. The dietary intervention used by Dawson-Hughes et al
differed from the current study in that it contained 0.2 g/kg less dietary protein, 16.1 mg/kg more
histidine and 52.5 mg/kg less phenylalanine. Differences in study design, study duration and
amino acid supplementation may have contributed to the discrepancy in directional change in
urinary calcium between the present study and the report by Dawson-Hughes et al.
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A BCAA intervention was not included in the present study. Two human clinical trials found no
effect of BCAA supplementation on urinary calcium or calcium absorption (13, 63). Civitelli et al
supplemented osteoporotic patients with three different amino acids including the BCAA, Lvaline, which did not induce a rise in intestinal calcium absorption (13). Similarly, DawsonHughes et al. (63) reported a blunted calciuric response in subjects consuming a diet rich in
leucine and isoleucine compared to those with high CaSR-AAA intakes. There are obviously
numerous other combinations of amino acids that need to be explored in relation to calcium
homeostasis, which is beyond the scope of this study.
Not all investigators have observed an effect of dietary protein on calcium absorption. Hunt et al
(35) and Ceglia et al (36), reported no differences in calcium absorption between different levels
of dietary protein when calcium intakes met or surpassed the RDA (35, 36) and dietary
phosphorous was not fixed (36). Higher calcium and phosphorus intakes could have masked
any potential regulatory actions of dietary protein on calcium absorption. It would be of interest
to examine the effect of graded calcium intakes in conjunction with different quantities or
combinations of amino acid supplements on calcium economy to determine if this has a
protective effect on calcium homeostasis in low dietary calcium environments.
The current study had a number of strengths including a tightly controlled cross-over design with
all meals provided by the metabolic kitchen at the Yale Center for Clinical Investigation. Good
dietary compliance was evident by consistency in urinary sodium. We targeted young Asian and
Caucasian women as these ethnic groups are at highest risk for osteoporosis in later adult life
(64). A recent analysis of NHANES (2003-2006) reported that women between the ages of 1940 who do not use calcium supplements are not meeting the current recommendations for
calcium (70). Thus, young Asian and Caucasian women would likely benefit from a nutrient
based, low-risk, therapeutic option, such as dietary protein/amino acid supplementation, to
maximize calcium absorption. Moreover, protein intake has decreased in women from 1970's to
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2006 (71). We chose to study a group of individuals who, as they age, are at greatest risk for
osteoporosis and depending on dietary protein intake could benefit from protein/amino acid
supplementation to optimize intestinal calcium absorption.
The study also had some limitations. Our sample size was small. It may be that larger studies of
longer duration will be needed to further clarify the impact of DAA on calcium economy. Some
subjects required vitamin D supplementation prior to starting their adjustment diets. However,
the number of study subjects requiring vitamin D supplementation was nearly equal for each
dietary intervention (DAA: 7 subjects, CaSR-AAA: 8 subjects, Control: 8 subjects) making
unlikely that this confounded our results. Time of menstrual cycle was not controlled for when
scheduling each study subject’s calcium absorption assessments. In initial studies from our
group examining the effect of increasing protein intake on calcium absorption using the same
dual-stable calcium isotope methodology as in our current report, we did not control for time of
menstrual cycle in premenopausal women (37, 38). We observed a quantitatively comparable
effect of dietary protein in men and postmenopausal women in whom cyclical changes in
reproductive hormone levels do not occur when compared to premenopausal women. Thus,
although we cannot exclude a contribution of variations in estrogen levels to our observed
results, given the above, this seems unlikely to have made a major contribution.
In summary, calcium absorption was assessed by dual-stable calcium isotopes in healthy
premenopausal women consuming a low-protein diet supplemented with CaSR-AAA or DAA for
six days. The addition of CaSR-AAA to a low-protein diet did not result in a significant rise or
decline in calcium absorption. Urinary calcium was significantly higher with arginine and lysine
supplementation, which could potentially be explained by a change in calcium absorption
efficiency.
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FIGURE LEGENDS
FIGURE 1 Flow diagram displaying recruitment, enrollment and randomization of study
subjects. Fourteen healthy young women took part in a cross-over design, feeding study where
they received three experimental diets in random order (control; CaSR-AAA, CaSR-activating
amino acids; DAA, Dibasic amino acids). n=14 for each experimental diet.
FIGURE 2 Mean urinary calcium (A) and intestinal calcium absorption (B) for fourteen healthy
young women on day 5 of the control and DAA supplemented low-protein diets. n=14 for each
experimental diet. Significantly different from the control diet by paired t-test: *P< 0.05,
**Different from control, P value > 0.05 and < 0.10, suggestive of a trend, ***Effect size = 0.54 ±
0.1. DAA, Dibasic amino acids.
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Table 1 Average amino acid content per gram of total protein in the low and high protein study diets

1

Amino acid
His

Amino acid
functional group
CaSR-AAA

Amino acid content of low
protein diet
(mg/g dietary protein)
25.3±0.6

Amino acid content of
high protein diet
(mg/g dietary protein)
28.2±0.2

Average amino acid content of
2
the diets
(mg/g dietary protein)
27

Phe

CaSR-AAA

75.4±0.8

76.5±0.6

76

Trp

CaSR-AAA

11.3±0.2

11.3±0.0

11

Arg

DAA

46.5±1.2

56.8±0.4

52

Lys

DAA

58.9±1.1

74.9±0.8

67

1

Values are presented as means ± SEM.
2
Average amino-acid content of the low and high protein diets was used to calculate amino acid supplementation.
CaSR-AAA, CaSR-activating amino acids; DAA, Dibasic amino acids.
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Table 2

Effect of CaSR-AAA and DAA supplementation on calcium-related metabolites and calcium absorption in young women

Control

CaSR-AAA Supplementation

1

DAA Supplementation

Day 1
14

Day 5
14

Day 1
14

Day 5
14

Day 1
14

Day 5
14

151 ± 13

163 ± 8

162 ± 12

155 ± 12

172 ± 14

166 ± 13

36 ± 6

31 ± 6

31 ± 7

30 ± 6

32 ± 9

31 ± 7

91 ± 5

97 ± 6

90 ± 5

91 ± 6

93 ± 5

94 ± 6

Sodium (mmol)

90.8 ± 12.6

74.9 ± 6.7

80.9 ± 10.7

86.4 ± 8.2

80.2 ± 7.5

90.1 ± 9.7

Calcium (mmol)

4.6 ± 1.1

2.9 ± 0.3

3.9 ± 0.6

3.3 ± 0.3

4.2 ± 0.6

3.8 ± 0.5

Phosphorus (mmol)

18.4 ± 1.8

11.4 ± 1.2

15.6 ± 1.7

12.0 ± 1.2

18.2 ± 1.4

12.7 ± 1.3

a

25.2 ± 1.4

c

Subjects, n
Serum metabolites
1,25-Dihydroxyvitamin D (pmol/L)
Intact PTH (nmol/L)
2

GFR (mL/min/1.73 m )
24-h urine metabolities

a
a

a

b

Calcium absorption
Intestinal calcium absorption (%)
1
a

22.3 ± 1.4

22.9 ± 2.0

Values are presented as mean ± SEM.
Significantly different from baseline of same intervention, P < 0.05.

b

Significantly different from control day 5, P < 0.05.
Different from control day 5, P value > 0.05 and < 0.10, suggestive of a trend.
CaSR-AAA, CaSR-activating amino acids; DAA, Dibasic amino acids
c
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FIGURE 1

Assessed for eligibility
(n = 65)

Excluded (n = 51)
• Not meeting inclusion
criteria (n=20)
• Declined to
participate (n=31)

Randomized to the three
experimental diets (n = 14):
• Control
• CaSR-AAA
• DAA

Completed the three
experimental diets (n = 14):
• Control
• CaSR-AAA
• DAA

Lost to follow-up
(n = 0)
Discontinued
intervention
(n = 0)

Analyzed
(n = 14)
Excluded from analysis
(n = 0)
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Intestinal Calcium Absorption (%)

Urinary Calcium (mmol/day)

FIGURE 2

A

B
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Chapter 4:
Establishment of an in vitro transport model for evaluating the effects of amino
acids and claudin-2 on total transepithelial Ca transport

Introduction
Controversy surrounds the role of dietary protein in calcium homeostasis. Dietary protein was
thought to have deleterious effects on the skeleton because the endogenous acid load
generated from the metabolism of sulfur-containing amino acids might induce osteoclastmediated bone resorption. The result is Ca being leached from bone as part of a homeostatic
mechanism in which bicarbonate is released from mineralized tissue to buffer the acid (47-50).
However, Kerstetter et al have demonstrated that moderate increases in dietary protein
significantly improve intestinal Ca absorption, in least in the short-term, without increasing bone
resorption (38).
The underlying mechanism by which dietary protein increases Ca absorption is unclear.
Gaffney-Stomberg et al. established an animal model to begin elucidating the mechanism for
protein-induced increases in intestinal calcium absorption (58). Rats were randomly assigned to
low (5%) or high (40%) protein diets for 7 days. All diets were isocaloric and contained 0.45%
Ca and 0.35% P. In rats, UCa paralleled protein intake. Rats consuming the high protein diet
absorbed and retained more Ca compared to the low protein group (48.5% vs. 34.1% and
45.8% vs. 33.7% respectively, p<0.01). Brush border membrane vesicles (BBMV) were
prepared from duodena of rats acclimated to the low or high protein diets. Ca uptake was
significantly increased in BBMVs from animals on the high protein diet indicating that protein
augments intestinal Ca absorption, in part, by increasing transcellular Ca uptake. However, the
expression of the known plasma membrane Ca channels, TRPV5 and TRPV6, was not induced
by a high protein diet (58). Since expression of TRPV5 and TRPV6 were not altered by dietary
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protein, Dr. Insogna’s laboratory undertook a whole genome microarray screen using RNA
isolated from duodenal enterocytes of rats ingesting the low or high protein diet to look for novel
Ca transporters. Claudin-2 (Cldn-2) was found to be upregulated by the high protein diet in the
microarray screen, a finding corroborated by qPCR, using duodenal RNA. Cldn-2 is a tight
junction protein that exhibits Ca selectivity. Its expression is induced by 1,25-dihydroxyvitamin
D. Increased expression of Cldn-2 at the tight junction increases calcium permeability (7). These
findings suggest that dietary protein could be affecting calcium transport by a Cldn-2-dependent
mechanism.
The constituents of dietary protein responsible for the increases in Ca uptake and absorption
are unknown. Furthermore, the function of Cldn-2 in total transepithelial calcium transport is not
well established. To investigate the mechanisms by which dietary protein exerts its effects on
intestinal Ca transport, and to determine if there is a direct effect of amino acids on enterocyte
Ca transport, an in vitro Ca transport model was developed in Caco-2 cells. Since Cldn-2 was
upregulated by dietary protein in our rat model, we also sought to determine the contribution of
this endogenous protein to Ca transport. Toward this end, Cldn-2 was stably suppressed in
Caco-2 cells and Ca transport was evaluated.

Materials and Methods
Materials
Caco-2 Bbe cells were kindly provided by Dr. Mark Mooseker (Dept of Molecular, Cellular &
Developmental Biology, Yale University) and purchased from America Tissue Culture Collection
(Rockville, MD). High-glucose DMEM, L-glutamine, D-glucose, phenol red powder, HEPES (≥
99.5%) and D-(+)-Raffinose pentahydrate were purchased by Sigma (St. Louis, MO). Qualified
FBS, L-glutamine, non-essential amino acids (NEAA), essential amino acids (EAA), puromycin
dihydrochloride and penicillin/streptomycin were purchased from Gibco/Invitrogen (Carlsbad,
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CA). KCl, Na2HPO4, glycine and NaCl were purchased from Fisher Scientific (Suwanee, GA).
KH2P04 and MgSO4 were purchased from J. T. Baker (Phillipsburg, NJ). OPTI-FLUOR LSCcocktail was purchased from Perkin Elmer, Inc (Waltham, MA). Collagen coated
polytetrafluoroethylene Transwell permeable supports (Corning Incorporated, Costar, Corning,
NY, catalog no. 3491) and Polyester Transwell permeable supports (Corning Incorporated,
Costar, Corning, NY, catalog no. 3460) were purchased from Corning Incorporated. pGIPZ
Lentiviral Human CLDN2 shRNA was purchased from Fisher Scientific – USA (Pittsburgh PA,
catalog # RHS4531-EG9075). Lenti-X HTX Packaging System, Lenti-X Concentrator and LentiX GoStixTM were purchased from Clontech (Mountainview, CA). iScript™ cDNA Synthesis Kit
and iTaqTM Universal Probes Supermix were purchased from BIO-RAD Laboratories (Hercules,
CA). Cldn-2 and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) TaqMan® Gene
Expression Assays were purchased from Applied Biosystems (Foster City, CA). Protease
inhibitors were purchased from Roche Diagnostic (Indianapolis, IN). Mouse anti-Cldn-2
antibody was purchased from Invitrogen (REF325600). Mouse anti-β-actin antibody was
purchased from Santa Cruz Biotechnology (sc-47778, Santa Cruz, CA).
Cell culture
Caco-2 cells were grown in T-75 flasks and routinely passaged using Trypsin/0.5% EDTA when
80-90% confluent. Cells were cultured in growth media containing high glucose DMEM, 10%
qualified FBS, 1% L-glutamine, 1% non-essential amino acids and 1% penicillin/streptomycin
and media was changed every 2-3 days. Caco-2 cells were maintained at 37ºC in a 5% CO295% air atmosphere. Caco-2 cells provide a model of intestinal epithelia, as they exhibit brush
border microvilli and apical enzymes including sucrase isomaltase, alkaline phosphatase and
aminopeptidase N. For over a decade Caco-2 cells have provided a well-established model for
the assessment of small intestinal transcellular flux of a number of compounds that is predictive
of in vivo absorption in humans (72, 73). In most of the studies described below, Caco-2 cells
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were studied at 21-days post-confluent at which time they are fully differentiated and assume an
enterocyte phenotype (74-76).
Amino acid treatments
As shown in the Table, moderate amino acid (MAA) transport treatment consisted of 20
essential and non-essential amino acids added to transport buffer (TB) and provided 1.914 mg
of total amino acids/mL. The final concentration of amino acids provided by the MAA treatment
was approximately 1.2-fold higher than the amount found in high glucose DMEM, the primary
constituent of regular Caco-2 growth media. High amino acid (HAA) transport treatment had the
same amino acid profile as MAA and provided 5.276 mg of total amino acids/mL, which is
approximately 3.3-fold higher than the concentration of amino acids in high glucose DMEM
(Table). Amino acid pretreatment was comprised of 1% FBS, penicillin/streptomycin and highglucose DMEM (1% FBS media) supplemented with MAA.
Diffusional phenol red transport studies
The methodology utilized in the current study for assessing diffusional phenol red flux across
Caco-2 monolayers is a modification of that previously published (24, 77). Phenol Red was
used to provide a simple assessment of paracellular transport (77). For phenol red transport
studies Caco-2 cells were seeded at a density of 3 X10^5 -5 X10^5 cells/well into 6-well plates
containing collagen coated polytetrafluoroethylene Transwell permeable supports. For these
experiments, Caco-2 cells were studied at 21 days post-confluence. These culture conditions
were chosen based on previous work by Suzuki and Hara who examined the effect of raffinose,
along with other non-digestible saccharides, on paracellular permeability in Caco-2 cells (78).
On the day of an experiment the media was removed and the inserts were rinsed two times with
room temperature Dulbecco’s phosphate-buffered saline (PBS). The permeable supports
containing the cells were transferred to fresh six-well plates containing 2.5 mL of freshly
prepared TB ((in mM) 140 NaCl, 5.8 KCl, 1.2 CaCl2, 0.34 Na2HP04, 0.44 KH2P04, 0.8 MgSO4, 20
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N-Z-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, 4 glutamine, and 25 glucose, pH 7.37-7.4)
(24, 76, 77). At time zero, 1.5 mL of transport buffer was added to the upper chamber of the
Transwells inserts. Upper chamber buffer consisted of the same buffer as the lower chamber
except it also contained Phenol Red (500 uM). Raffinose (100 mM), a non-digestible
oligosaccharide, which non-specifically reduces transepithelial resistance (TER) and increase
paracellular permeability in Caco-2 cells, was included in the TB as a positive control (78).
Following the addition of transport buffer, cells were incubate at 37ºC in a 5% CO2-95% air
atmosphere (with manual shaking approximately every 30 min for 45 seconds) for 90 minutes,
120 minutes or 4 hours. At the end of each experiment, duplicate 300 ul aliquots of lower well
buffer was removed and transferred to an eppendorf tube and 30 µl of 0.1 N NaOH was added
to each sample. Absorbance was read at 560 nm following a 5 min incubation period. The
concentration of phenol read appearing in the lower buffer after 90 minutes, 120 minutes and 4
hours of transport was determined using a standard curve of phenol red.
Total transepithelial 45Ca transport studies
For total transepithelial 45Ca transport studies, Caco-2 cells were seeded into 12-well plates with
Polyester Transwell permeable supports at a density of 56,000 cells/cm2. Similar techniques
were utilized to assess the effect of various nutrients on calcium transport (23-25, 76, 77). To
validate the in vitro Transwell transport model 1,25-dihydroxyvitamin D, a known regulator of
calcium transport (76), was used as a positive control. Cells were pre-treated with 1, 25dihydroxyvitamin D in 5% FBS growth media for 24 hours prior to the start of the study. 1,25dihydroxyvitamin D validation experiments mimicked the 4 hour phenol transport studies
summarized above, however, 45Ca was used in place of phenol red to assess total transepithial
calcium transport. At Time 0, 45Ca was added to the upper chamber in the presence of TB
(control) or TB to which 1,25-dihydroxyvitamin D (100 nM) had been added. Approximately 5-10
min after addition of 45Ca triplicate 25 ul aliquots were removed from the top (baseline samples)
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and bottom wells. After 4 hours, triplicate 50 ul samples were taken from the bottom chambers.
Baseline and 4 hour samples were added to scintillation vials containing OPTI-FLUOR LSCcocktail. Radioactivity was determined using a liquid scintillation counter (Tri-Carb 2800TR).
Total transepithelial Ca transport was estimated as the amount of 45Ca appearing in the
basolateral buffer at 4 hours, expressed as a percentage of the total 45Ca applied to the upper
chamber at Time 0. Studies to evaluate the effect of pH on epithelial permeability were
conducted using the same methodology, except the duration of 45Ca transport measurements
was extended to 6 hours and the duration of amino acid pretreatment varied as detailed below.
Generation of stable Cldn-2 knockdown in Caco-2 Bbe by lentiviral vector
Lentiviral preparations were generated according to the manufacturer’s instructions. Briefly, 9095% confluent Lenti-X 293T packaging cells were transfected with pGIPZ Lentiviral vector
containing tGFP reporter, puromycin resistance gene, and Cldn-2 specific or non-silencing
shRNA (scrambled shRNA, control) using the Lenti-X HTX Packaging System. Forty-eight
hours after transfection, lentiviral supernatants were harvested and mixed with the Lenti-X
Concentrator. Virus production was verified using Lenti-X GoStixTM. Forty-eight hours prior to
lentiviral transduction, Caco-2 Bbe cells were plated in 24-well plates at a density of 3.1X 104
cells/well in their complete growth medium. Caco-2 cells were transduced with viral supernatant
using Polybrene (as per the manufacturer’s protocol), centrifuged at 2,000 RPM for 1.5 hours
and incubated overnight. Infected cells were incubated for an additional 48 hours in complete
growth medium before the initiation of antibiotic selection with 8 µg/mL puromycin
dihydrochloride (final concentration). Stable transfectants were routinely passaged using
Trypsin/0.5% EDTA when 80-90% confluent. Cells were cultured in normal growth media
(described above) containing 8 µg/mL puromycin dihydrochloride with a media change every 23 days. To assess infection efficiency, Caco-2 cells were imaged using fluorescence microscopy
to visualize GFP expression.
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Quantitative analysis of Cldn-2 knockdown by Real Time-PCR (qPCR) and Western blot
qPCR
Total RNA was isolated from approximately two week post confluent non-infected Caco-2 cells
(control), or Caco-2 cells stably transduced with 5 different Cldn-2 specific shRNAs or
scrambled shRNA GIPZ lentiviral constructs. cDNA was synthesized using the iScript™ cDNA
Synthesis Kit and the RT reaction was performed on a PTC-100 PCR machine (MJ Research
Inc., Waltham, MA) using the following protocol: 25°C x 10 min, 43°C x 45 min, 95°C x 5 min.
qPCR was performed using a TaqMan® Gene Expression Assay for Cldn-2 (Rn02063575_s1)
and iTaqTM Universal Probes Supermix. GAPDH was used as an endogenous reference
(Hs99999905_m1).
Western Blot
Caco-2 cells were grown in 60 mm dishes and lysed with RIPA buffer (1% Triton-X 100, 1% Na
deoxycholate, 0.1% SDS, 158 mM NaCl, 5 mM EDTA, 10 mM Tris pH 7.2) containing protease
inhibitors (Roche Diagnostics Corporation, Indianapolis, IN). Cell lysates were removed using a
plastic cell scraper. Lysates were incubated on ice for 10 min and clarified, by centrifugation at
14,000 x g for 15 min at 4°C. The clarified lysates were assayed for protein content using a
BCATM protein assay (Thermo Scientific, Rockford, IL). SDS-PAGE gel electrophoresis and
western blotting were performed using standard techniques. A mouse monoclonal antibody to
Cldn-2 (2 ug/ul) that detects a band of approximately 22-23 kDa was added in 5% skim milk at
4ºC overnight. A secondary antibody, anti-Mouse (1:1000), in 5% skim milk was applied for 1
hour. β-actin was used as a loading control.
Statistics Analyses
Statistical analyses and graphical summaries were performed using GraphPad Prism ® version
6.00 for Windows (GraphPad Software Inc., La Jolla, CA). All values are presented as means ±
SEM. An unpaired t-test was used to analyze experiments conducted on two groups. When
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three or more groups were studied an unpaired t-test were used to compare each experimental
treatment to control of the same time point. For all statistical analyses, differences with a P
value <0.05 were considered significant.

Results and Discussion
Transport of phenol red in Caco-2 monolayers grown on collagen coated polytetrafluoroethylene
Transwell supports
We initially attempted to assess paracellular Ca flux in Caco-2 cells using phenol red. Caco-2
cells were treated either TB (control) or raffinose, which is known to non-specifically open the
tight junction. Unexpectedly, treatment with raffinose for 90 minutes did not alter phenol red
transport in Caco-2 cells. In fact, phenol red flux was suppressed in cells exposed to raffinose
for 120 minutes (P = 0.006; Figure 1a). To determine if the duration of exposure to raffinose
was insufficient to measure an effect on paracellular transport, the treatment was extended to 4
hours. Exposing Caco-2 cells to raffinose for 4 hours resulted in a 1.2-fold increase in phenol
red transport compared to TB (control; P= 0.17; Figure 1b). The fact that phenol red was without
a significant effect in this model prompted a reevaluation of all aspects of this in vitro system.
Upon review it was noted that the collagen coated polytetrafluoroethylene Transwell supports
used in this experiment have a membrane thickness of 50 µm which is five-times the thickness
of polyester Transwell permeable inserts. We hypothesized that the relatively thick membrane
represented a physical barrier that precluded us from detecting a change in paracellular Ca
transport. We therefore, substituted the polytetrafluoroethylene supports for polyester inserts,
and replaced phenol red with 45Ca, a marker specific for calcium flux, in an effort to improve the
sensitivity and specificity of the model.
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Validation of total transepithelial 45Ca Transwell transport model
Transwell inserts with a semipermeable membrane were previously used to examine
transepithelial, transcellular and paracellular transport pathways in the presence of various
drugs and nutrients. Such a model requires independent validation as a wide variety of
methodologies have been previously published (23-25, 72, 76, 77, 79). As expected, treatment
with 1,25-dihydroxyvitamin D significantly increased transepithelial Ca transport (Figure 2; 2-fold
increase; P=0.0132), indicating that this model responds normally to vitamin D. To further
validate the model, the apical side of the Caco-2 monolayer was exposed to an acidic
environment by the addition of a low pH buffer (pH = 3) to the upper chamber. Total
transepithelial Ca flux was 4.5-fold higher after treatment with an acidic buffer compared to TB
with a neutral pH (Figure 3). This observation is in agreement with in vitro work by Tang and
Goodenough who demonstrated increased Ca permeability in a low pH environment (80).
Acute effect of amino acids on total transepithelial 45Ca transport
Our primary objective was to assess if amino acids have a direct effect on the enterocyte and
thereby increase calcium transport. To assess the effect of amino acids on total transepithelial
calcium transport, we first supplemented TB with an amount of amino acids comparable to that
found in high glucose DMEM (Table), which we considered to be moderate in amino acid
concentration (MAA). High glucose DMEM is the primary constituent of regular Caco-2 growth
media and contains more amino acids than other commercially available media such as EMEM.
For this reason we did not consider the amount of amino acids provided by the MAA treatment
to be low or restrictive. Alternatively, we did not feel that this treatment provided additional
amino acid supplementation above that provided by normal growth media. For these
experiments we exposed the apical side or top of the monolayer and both the top and bottom
sides of the monolayer to MAA. Exposing both sides of the Caco-2 monolayer to MAA for 6
hours did not alter calcium transport compared to control (TB). However, the addition of MAA to
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the top chamber resulted in a 1.6-fold increase in total transepithelial calcium transport (Figure
4; P=0.069). As with most nutrient effects, the effect of MAA treatment appeared modest and
was comparable to the previously reported trans-10, cis-12 conjugated linoleic acid-induced 2fold increase in total transepithelial 45Ca transport (25). Our in vivo experiments in both rats and
humans examined intestinal Ca transport after 5-7 days of dietary protein supplementation. We
therefore, were interested in whether a longer in vitro treatment period in our Caco-2 cell model
would have a greater effect on total transepithelial transport. However, with longer treatment
protocols the issue of nutrient deprivation in cells cultured in low amino acid conditions needed
to be addressed. To resolve these concerns, the TB control was reformulated.
Effect of prolonged amino acid supplementation on total transepithelial 45Ca transport:
Preliminary Results
Prolonged amino acid supplementation studies consisted of 72 hours of amino acid
pretreatment followed by 6 hour assessment of total transepithelial Ca transport in the presence
of glutamine, glycine and 12 additional EAA in TB (control) or HAA treatment (Table). The TB
control used in these experiments differed from our original TB in that it contained glycine (0.03
mg/mL) at a concentration identical to that found in high glucose DMEM and EAA (1.2 mg/mL),
and provided a final concentration of 1.778 mg total amino acids/mL. As in our previous
experiments, both conditions contained L-glutamine (a source of nitrogen for the synthesis of
vitamins, amino acids and nucleotides), which is necessary for cell proliferation and
differentiation. In nutrient-deprived states L-glutamine can be used for energy and maintenance
of protein synthesis in Caco-2 cells (81-83). Thus, these experiments were designed to examine
the effect of amino acid supplementation beyond the amount provided by normal growth media,
and represents a better in vitro model for our human and animal studies (38, 58) than the acute
amino acid transport experiments (described above). Prolonged amino acid supplementation
significantly augmented total transepithelial Ca transport compared to control (Figure 5; 1.6-fold
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increase; P=0.0048). These data are from one experiment and need to be repeated in order to
confirm this potentially important finding.
To date, it is unclear if amino acids exert an effect on the transcellular, paracellular or both
calcium absorption pathways as our model cannot distinguish between these two transport
mechanisms. The microarray screen summarized in the Introduction raises the possibility that
dietary protein or amino acids augment paracellular Ca transport by increasing expression of
tight junction protein Cldn-2. Since Cldn-2 is a Ca specific, pore-forming Cldn, it is reasonable
to believe that Cldn-2 has a major role in Ca transport. In order to directly address this
hypothesis, Cldn-2 was stably suppressed in Caco-2 cells and 45Ca transport studies were
repeated.
Confirmation of Cldn-2 knockdown in Caco-2 Cells
qPCR analysis using RNA isolated from Caco-2 cells expressing shRNAs directed against Cldn2 demonstrated effective knockdown of Cldn-2, with two of a panel of 5 shRNAs resulting in a ≥
88% suppression of the Cldn-2 transcript (Figure 6a-b). Western blot analysis revealed that
shRNA 3 was the most effective shRNA (6c-d). Scrambled shRNA did not appear to alter the
level of expression of Cldn-2 (6c-d), which suggests that lentiviral infection did not induce offtarget effects. GFP expression, a marker of transduction efficiency and shRNA expression,
appeared relatively consistent between Caco-2 cells infected with scrambled and Cldn-2
specific shRNAs (6e).
Effect of stable Cldn-2 knockdown on total transepithelial 45Ca transport
Of the 23 distinct Cldns identified in humans (84), Cldn-2 and -12 are characterized as Ca
permissive tight junction proteins, which, through transient knockdown in Caco-2 cells, were
proposed to be involved in 1,25-dihydroxyvitamin D-induced Ca transport (7). Overexpression of
Cldn-2 and Cldn-12, but not Cldn-7 increased Ca transport in Caco-2 cells (7).

41

As shown in Figure 7, stable knockdown of Cldn-2 in post-confluent Caco-2 cells elicited more
than a 3-fold reduction in total transepithelial Ca transport (P< 0.0001). To our knowledge we
are the first to demonstrate an independent role for endogenous Cldn-2 in total transepithelial
Ca transport in Caco-2 cells. Overexpression studies are inherently limited since they result in
highly unphysiologic levels of the target protein. Our knockdown study establishes a role for
Cldn-2 in Ca transport at endogenous levels in Caco-2 cells. It is not unreasonable to believe
that Cldn-2 exhibits a functional role in intestinal Ca transport, as other members of the Cldn
family are important mediators of Ca handling in other tissues. For example, under low dietary
Ca conditions, Cldn-16 and -19 function together to form a Ca selective pore for reabsorption of
Ca in the thick ascending limb of Henle. Conversely, when Ca intake is high, activation of the
calcium sensing receptor results in upregulation of Cldn-14. Cldn-14, in turn, can interact with
Cldn-16 to block Ca reabsorption and increase Ca excretion by the kidney (85). Results from
the present study provide further support for Cldn regulation of the Ca economy.
As noted in the Introduction, we have initially focused on Cldn-2 based on the results of our
microarray screen. Our Caco-2 cell line in which Cldn-2 was largely eliminated can now be used
to examine the contribution of Cldn-2 to the effects of amino acids on total transepithiel Ca
transport. It will also be of interest to investigate if diminished expression of Cldn-2 disrupts tight
junction architecture or alters expression of other tight junction proteins such as cation pore
sealers that could impede Ca permeability (4).
Despite its several strengths, our in vitro model also has limitations. Post-confluent Caco-2 cells
provide a well-established in vitro model of the small intestine, however, this model does not
allow for differentiation between segments of the small intestine. In the Caco-2 cell model, the
pH of the culture media was fixed between 7.37-7.4. As shown in Figure 3, pH has a profound
effect on Ca permeability. Since the pH varies along the course of the small intestine our model
does not adequately capture the pH influence on Ca transport (86). Lastly, our current model
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cannot distinguish between transcellular and paracellular Ca transport. However, with the use of
dyes such as lucifer yellow which is restricted to the extracellular space should in combination
with 45Ca transport studies allow us to assess the contribution of paracellular Ca transport to the
effect of amino acids on transepithielal Ca transport.
Conclusion
In summary, the current study established and validated an in vitro model for 45Ca transport.
The model permitted an initial assessment of the direct effect of amino acids on total
transepithelial Ca transport. A trend towards increased total transepithelial Ca transport was
observed when the apical side of post-confluent Caco-2 cell monolayers was exposed to
essential and non-essential amino acids for 6 hours. Preliminary results from prolonged amino
acid treatment experiments showed significantly enhanced Ca transport, however, corroborative
studies are warranted. In subsequent studies, the Caco-2 transport system was used to
establish the role of endogenous Cldn-2 in total transepithelial Ca transport, and demonstrated
a significant reduction in Ca transport when Cldn-2 was suppressed. This is the first study to
generate a stable Cldn-2 knockdown in Caco-2 cells and provides evidence for role of Cldn-2 in
Ca transport in the absence of pharmacologic or hormonal agonists. The present work will also
allow us to directly address the contribution of Cldn-2 to amino acid-induced increases in Ca
transport.
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Table. Amino Acid Treatments
Amino Acid (mg/mL)

DMEM

MAA1

HAA1,2

Glycine
L-Arginine hydrochloride
L-Cystine 2HCl
L-glutamine
L-Histidine hydrochloride H20
L-Isoleucine
L-Leucine
L-Lysine hydrochloride
L-Methionine
L-Phenylalanine
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine disodium salt dihydrate
L-Valine
L-Alanine
L-Asparagine
L-Aspartic Acid
L-Gutamic Acid
L-Proline

0.030
0.084
0.063
0.584
0.042
0.105
0.105
0.146
0.030
0.066
0.042
0.095
0.016
0.104
0.094

0.016
0.263
0.050
0.585
0.088
0.109
0.109
0.151
0.031
0.069
0.022
0.099
0.021
0.075
0.098
0.019
0.028
0.028
0.031
0.024

0.085
0.922
0.175
0.585
0.306
0.382
0.382
0.529
0.110
0.241
0.077
0.347
0.074
0.263
0.341
0.065
0.096
0.097
0.107
0.084

Total Amino Acids (mg/mL)

1.606

1.914

5.267

1

Includes glutamine from transport buffer

2

Includes glycine from transport buffer
MAA, moderate amino acid transport treatment
HAA, high amino acid transport treatment
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Figures

a

b

Figure 1a-b. Relative diffusional phenol red transport (top to bottom) across monolayers of
Caco-2 cells (Mooseker, approximately 21-day post confluent) at 90 and 120 min (1a) and 4
hours (1b). n = 2 monolayers grown on collagen coated polytetrafluoroethylene Transwell
inserts exposed to transport buffer (TB, control) or 100 mM raffinose.
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Figure 2. Total transepithelial 45Ca transport across monolayers of Caco-2 cells (Mooseker,
approximately 13-17 days post confluences) at 4 hours. Monolayers grown on polyester
membrane Transwell inserts exposed to transport buffer (TB, control) for 4 hours or 1,25 vitamin
D added to 5% FBS Caco-2 growth media for 24 hr prior to transport study and then added to
TB 4 hr during transport study. n=9 monolayers per condition.

Figure 3. Total transepithelial 45Ca transport across monolayers of Caco-2 cells (Mooseker, 2627 days in culture) at 6 hours. Monolayers grown on polyester membrane Transwell inserts
exposed to transport buffer, pH of 7.37 (TB, control, n= 4) or acidic buffer, pH of 3 (added to the
top chamber only, n= 3).
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Figure 4. Total transepithelial 45Ca transport across monolayers of Caco-2 cells (Mooseker, 26
days in culture) at 6 hours. Monolayers grown on polyester membrane Transwell inserts
exposed to transport buffer (TB, control), moderate amino acid treatment (MAA, amino acids
added to TB) on one side of the monolayer (MAA Top), or MAA on both sides of the monolayer
(MAA Top and Bottom). n=3 monolayers per condition.
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0.0048

Figure 5. Monolayers grown on polyester membrane Transwell inserts (ATCC, 25 days in
culture) pretreated with 1% FBS media (pretreatment control) or 1% FBS media supplemented
with MAA (moderate amino acids) for 72 hours. Total transepithelial 45Ca transport at 6 hours in
the presence of TB supplemented with glutamine, glycine and 12 additional essential amino
acids (EAA) (control) or high amino acid treatment (HAA, amino acids added to control).
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c

d
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e

f

Figure 6a-f. Confirmed knockdown efficiency of claudin-2 (Cldn-2) in Caco-2 cells by lentiviral shRNA
(Moosker, 2-weeks post confluence). Non-infected Caco-2 cells (control), Caco-2 cells infected with nonsilencing, scrambled shRNA (control) or claudin-2 specific shRNAs. Confirmation of knockdown of Cldn-2
by qPCR (a-b, control: GAPDH). Confirmation of knockdown of Cldn-2 by Western blot (β-actin used as a
loading control, c). Relative expression of Cldn-2 in c normalized to β -actin, d). Caco-2 cells infected with
scrambled shRNA (control) stably expressing GFP (e, left panels: fluorescent light, right panels: white
light) or claudin-2 specific shRNA 3 stably expressing GFP (f, left panels: fluorescent light, right panels:
white light) imaged by fluorescent microscopy.
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Figure 7. Total transepithelial 45Ca transport across monolayers of Caco-2 cells infected with scrambled
(control) or claudin-2 specific lentiviral shRNA (Mooseker, 25 days in culture). Transport assessed at 6
hrs in transport buffer supplemented with glycine, glutamine and 12 additional essential amino acids
(EAA). n=6 monolayers per condition.
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Chapter 5:
Conclusions and Future Study Directions

We previously supplemented a low protein diet with dibasic amino acids and observed a trend
towards increased Ca absoption in young women. Our sample size of 14 and six day study
design may have hindered us from observing a statistically significant effect. Larger and longer
clinical trials should provide more robust estimates of the magnitude of this effect and its
duration. It would be of interest to explore the impact of dibasic amino acids along with other
combinations of amino acids on calcium economy in populations who are at risk for calcium
malabsorption. For example individuals with Crohn’s or celiac disease would benefit from nonsatiating, nutrient based, low-risk, nutritional therapies to optimize calcium absorption.
Furthermore, individuals with protein intakes below the RDA may benefit from amino acid
supplementation to improve Ca economy. Lastly, the effect of amino acid supplementation on
Ca absorption may prove to be beneficial during critical stages in life such as infancy.
We have established and validated an in vitro model for 45Ca transport in Caco-2 cells and have
preliminary evidence to suggest that 72 hours of treatment with amino acid enriched media
increases total transepithelial Ca transport. Future experiments will need to corroborate these
findings. Our current manual method requires an approximately 25-day culture period and
allows for up to 24-wells per experiment. Recent advances in culturing systems have decreased
the required culturing period for Caco-2 cell differentiation to 3-7 days (87), allowing for
increased efficiency and decreased risk of contamination. Furthermore, by collaborating with
pharmaceutical companies we can automate this process with the use of a liquid handler and
articulated arm (86), thereby increasing standardization and reducing inter- and intra-assay
variability brought forth by human error.
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Our current in vitro Ca transport system can be used in the future to assess the effect of
different combinations and concentrations of amino acids on total transepithelial transport.
Understanding the minimal amino acid requirements of Caco-2 cells will allow us to further
improve our control treatment. We may be able to lower the amino acid concentration of our
control without causing nutrient deprivation or damage, which could increase the magnitude of
effect observed with amino acid supplementation. Cell viability studies and assessment of
lactase dehydrogenase release after exposure to different amino acid concentrations will be
informative in evaluating any potential cytoxic effects of our treatments. To better understand
the contribution of paracellular Ca transport to the effect of amino acids on transepithelial
transport, dyes such as lucifer yellow which is restricted to the extracellular space, can be
included in our model.
Data from our laboratory provide evidence for the role of Cldn-2 in total transepithelial Ca
transport in vitro. We recently generated a stable Cldn-2 knockdown cell line and observed a
significant decline in total transepithelial Ca transport. We plan to use this model to address the
contribution of Cldn-2 to amino acid-induced increases in Ca transport. In order to corroborate
our in vitro findings, it is necessary to explore the role of Cldn-2 in Ca transport in vivo. This
would require conditional deletion of Cldn-2 in a mouse model. For theses experiment, Villin-cre
transgenic mice (JAX® Mice database, B6.SJL-Tg(Vil-cre)997Gum/J), who express Cre
recombinase under the direction of the mouse villin 1 promoter, would be crossed with a strain
containing a loxP site-flanked sequence for Cldn-2. Cre-mediated recombination would allow for
tissue-specific deletion of Cldn-2. Recombination would occur in villi and crypt cells of the small
and large intestines, thereby generating gut-specific gene-deficient mice for Cldn-2. Ca
absorption could be assessed by 45Ca skeletal incorporation.
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